Xavier C.
- Country
- France
- Department
- hematologie
Research Overview
Data & Insights
Has run more than one trial at 11 of 35 partner sites.
Specializations
Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
The clinical research profile includes hematologic malignancies with a strong focus on myelodysplastic syndromes, especially lower-risk disease with anemia and transfusion dependence, as well as higher-risk disease in patients not eligible for transplantation. Work also extends to chronic myelomonocytic leukemia and related onco-hematology settings.
- Lower-risk MDS with anemia
- Higher-risk MDS in transplant-ineligible patients
- CMML with elevated-risk features
Therapeutic interests center on improving blood count recovery, reducing transfusion needs, and expanding options for patients with limited curative alternatives.
Multiple Myeloma
The investigator is involved in multiple myeloma research across newly diagnosed and relapsed disease, with emphasis on older and transplant-ineligible patients. The portfolio includes treatment strategies for frail individuals and those requiring non-intensive approaches in routine hematology practice.
- Newly diagnosed multiple myeloma
- Relapsed multiple myeloma
- Frail and transplant-ineligible patients
Therapeutic interests also include response optimization and disease control in settings where long-term treatment selection is central to care.
Myeloproliferative Neoplasms
Another major area of activity is myeloproliferative neoplasms, including polycythemia vera, essential thrombocythemia, and myelofibrosis. The research landscape reflects interest in disease-related anemia, thrombotic risk, and chronic symptom burden across these overlapping disorders.
- Polycythemia vera
- Myelofibrosis
- JAK2V617F-positive MPN
Therapeutic focus includes strategies aimed at preventing vascular complications and addressing progressive marrow disease.
Chronic Lymphocytic Leukemia
The investigator also participates in studies in chronic lymphocytic leukemia, with attention to elderly patients, frail populations, and individuals with high-risk biological features. This area includes treatment questions relevant to disease control in early and established CLL.
- High-risk CLL
- Frail or elderly CLL patients
- SLL
Therapeutic interests are centered on maintaining disease control while accommodating age-related vulnerability and treatment tolerance.
Urothelial Cancer and Colorectal Surgery
The clinical portfolio also includes research in non-muscle-invasive urothelial carcinoma of the bladder and perioperative infection prevention in colorectal surgery. These areas broaden the investigator’s activity beyond hematologic disease into urologic oncology and surgical care.
- Non-muscle-invasive bladder cancer
- Carcinoma in situ of the bladder
- Colorectal surgical site infection prevention
Therapeutic interest in these settings is directed toward local disease control and perioperative outcome improvement.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.